Article - Page 5 of 6 - Echosens

Choose your location

Choose your language

FibroScan^® 630 Expert: Complete, Non-invasive Solution Offers Effective Management and Risk Stratification for Patients with Cirrhosis and Portal Hypertension

Type 2 diabetes: search for « fatty liver »

Interest of a liver exploration for an early diagnosis of NASH

FibroScan^® and the role of liver stiffness

VCTE™& elastography

COVID-19 Impact: Higher Risks of Severity Among Obese and Chronic Liver Disease Patients

FibroScan^® Recommended for Hepatitis C Patients

Echosens Observes National Drug and Alcohol Facts Week 2021

Economic Analysis Model Suggests Screening People for Fibrosis With Non-Invasive Tests Cost-effective

Innovative FAST™ Score Helps Clinicians Address the Epidemic of Active Fibrotic NASH

Country*
Email*
By subscribing, I agree that Echosens collects and uses my data in accordance with the Privacy Policy.
Comments
This field is for validation purposes and should be left unchanged.